Ares Systematic Credit Ltd

Position in LGND — Ligand Pharmaceuticals Inc

CIK 2135379 LONDON, X0

Position in LGND

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$146,665

New position

Shares Held

464

first reported quarter

Ownership

0.002%

of shares outstanding

% of Portfolio

0.30%

of 13F equity value

Holder Rank

#313

of 406 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Ares Systematic Credit Ltd holds $1,191,129 across 3 Biotechnology names. LGND ranks #3 (12.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVAX	Novavax Inc	80,155	$755,060
2	JAZZ	Jazz Pharmaceuticals plc	1,201	$289,404
3	LGND	Ligand Pharmaceuticals Inc This page	464	$146,665

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$146,665	464	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.